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Summary 
The following article presents the epidemiological situation in Poland over the 2007-2017
period.  The  article  is  based  on  the  analysis  of  “Contagious  diseases  and  toxoinfections
in Poland” and “Vaccination in Poland” surveys and pamphlets from the State Department of
Hygiene. Supplementary information concern infection by the virus, clinical manifestation,
detection,  diagnostic  procedure  and  vaccination  against  TBE  virus.  The  results  were
developed using a descriptive method.
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Introduction
Tick-borne encephalitis  (TBE) is a viral  infectious  disease involving the central  nervous
system. TBE is caused by tick-borne encephalitis virus (TBEV), member of the genus Flavivirus in
the  family  Flaviviridae.  TBEV is  transmitted  by the  bite  of  several  species  of  woodland ticks
infected by the virus, including  Ixoides scapularis, Ixoides ricinus  and  Ixoides persulcatus, it  is
rarely transmitted by drinking non-pasteurized milk of an infected cow. The virus causes a wide
spectrum of infections, including: meningitis, meningoencephalitis, encephalitis, encephalomyelitis
and poliomyelitis-like  disease  [1, 24].  TBEV is  endemic  in  the  regions  of  central,  eastern  and
northern Europe, stretching east through Russia, through Siberia all the way to China [pict. 1]. In
2009, Sweden had the highest reported TBE morbidity of Scandinavian countries [2]. In some parts
of Europe, for ex. in Czech Republic, the occurrence of TBEV has been rising since the 70s, which
is partly due to climate change and global warming [19, 20]. Tracking the dynamic of the virus and
new outbreaks calls for regular data actualization in order to ensure the safety of the population and
the people visiting the endemic regions. The understanding of the life cycle of the virustransmitting
tick species and their natural hosts, as well as the susceptibility to infection of human population in
regard to the season and climate, are key factors in preventing tick-borne diseases [11, 18]. In most
European countries  TBE belongs to  the  group of  (obligatory)  notifiable  diseases.  However  the
definition and report procedures vary across the endemic region. In Poland the criteria for reporting
a TBE case consist of the occurrence of neurological symptoms and stating the diagnosis based
on laboratory test  results  including:  the presence of specific  IgM and IgG (in plasma,  CSF) or
confirmed  synthesis  of  specific  antibodies  or  a  positive  outcome  of  FAVN  test  (fluorescent
antibody  virus  neutralization  test)  (confirmed  case)  or  the  presence  of  specific  IgM in  plasma
(patients unvaccinated to TBE and/or other flaviviruses) (highly probable case) [24]. There is no
effective treatment against TBEV. The only effective method of prevention is TBE vaccination [3].
The  podlaskie  voivodship  is  the  region  with  the  highest  risk  of  TBEV  infection  in  Poland.
Currently, there are 4 anti-TBEV vaccine types available in Poland.
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Picture 1. Map of endemic regions for TBE in Europe (  ares where TBE virus has been detected)
Epidemiology 
TBE is a zoonosis caused by viruses transmitted by ticks. In Poland over the 2007-2017
period, TBE accounted for 56% of all cases of encephalitis caused by viral infections [fig. 1]. Other
causes of viral encephalitis include infections by: HSV-1, EBV, VZV, flu virus, rubella, mumps and
measles  viruses.  The  epidemiology  of  tick-borne  encephalitis  includes  aspects  such  as  age,
geographic latitude,  landscape,  agricultural  activity,  migration,  climate change, political  changes
and the abundance of host organisms [11, 17]. In the cited literature, there is no mention of the
possibility of transmission of TBE from the mother to the foetus via placenta. A PubMed article
describes a case of a woman in 37th week of gestation/pregnancy being infected by TBEV. The
patient developed meningoencephalitis without permanent neurological damage. The woman gave
birth  to a healthy  offspring  in  40th week of  gestation.  The  baby was  tested  for  anti-TBE virus
antibodies in both IgG and IgM in the 30th month of life, both results were negative. Future test
results came back negative confirming that the baby has not been infected during pregnancy [1].
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Figure 1. TBE cases in comparison to all viral encephalitis in 2007- 2017 in Poland
The most investigated and best known endemic focus of TBEV in Poland is the forest of
Białowieża which remains an active focus of TBEV. Large TBEV morbidity rate of that region is
due to the extensive forests which provide a good/excellent environment for the infected ticks [fig.
2]. Over the 2007-2017 period the TBE cases reported from podlaskie voivodship accounted for
48% of total cases in Poland. 
Multiple species of ticks are capable of transmitting TBE virus, however the species playing
the  main  role  in  virus  transmission  are  Ixodes  ricinus  in  Europe  and  Iodes  persulcatus  and
Haemophysalis concinna in Russia [4]. Ticks from the Ixodes genus have a three-host life cycle
involving developmental stages of egg, larvae, nimf and adult form. Their full lifecycle takes 2-4
years to complete. Through every stage of life, the ticks need blood for further development. There
are multiple stimuli such as: temperature and the smell of lactic acid (present in sweat), informing
the tick of a potential host nearby [23]. In order to survive the ticks need at least 80% relative air-
humidity.  This  leads  to  believe  that  air  humidity  is  the  fundamental  condition  for  the  ticks  to
survive and the primary factor limiting the search time a tick can spend on finding a host organism.
The rise of air temperature plays just as big of a role in the increase of morbidity rate in tick-
transmitted diseases [21, 22].
The ticks’ saliva contains desensitising substances which makes the ticks bite undetectable.
Typical  loci  for  tick  bites  are  the  skin  covering  the  head,  ears,  large  joints,  upper  and  lower
extremities [5].
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Figure 2. The number of cases on TBE in Poland in 2017 by voivodships
According to the data from the National Institute of Public Health – State Department of
Health,  the number of new cases of TBE virus infections  in Poland closely correlates  with the
seasonal activity of the ticks [fig.3]. Most infections in Poland occur between April and November,
where two peak morbidity rates can be identified: the summer peak (June, July) and the autumn
peak (September, October) [6]. 
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Figure 3. The number of cases in particular quarters of 2007-2017
In 2007 there were 233 reported cases of TBEV infections in Poland, in 2017 the number of
cases increased to 23. The highest number of cases has been reported in 2009 counting 351 cases,
the  lowest  number  of  cases  was  reached  in  2015  with  149  reported  infections.  Based  on  the
statistics mentioned above, a conclusion can be drawn that the number of reported TBE cases has
been fluctuating  over  the 2007-2017 period,  furthermore over 2015/2016 period the number  of
cases has almost doubled [fig. 4]. All reported  cases of TBE in Poland were hospitalized [6].
Figure 4. The number of cases of TBE in Poland in 2007-2017
303
The rise of morbidity rates of TBE since the 90s in Poland has been a topic of discussion for
the recent years. Multiple reasons have been identified. Currently, the factors thought to be had the
most influence on the rising morbidity rate are: the climate change having a positive effect of the
conditions in areas inhabited by the ticks, constant improvement of the infection reporting system
and  detection methods of TBE virus, increased recreational activity of human population in areas
inhabited by infected ticks [7, 24]. 2/3 of TBEV infections in human population are subclinical or
present no symptoms on examination, this suggests that not all cases have been reported and the
number of total cases is larger than the number of reported cases. This makes the risk of infection
by TBEV in the human population difficult to estimate [23, 25].
Clinical manifestation of TBE 
The risk of developing TBE from the bite of a tick in a patient in central Europe, who has no
specific  immunity  to  TBEV,  ranges  between  0,003% and  0,75%.  In  the  majority  of  cases,  an
infection by TBEV presents little to no symptoms. The clinical appearance of TBE and the intensity
of its course depends on the species of pathogen [12, 18]. After the TBE virus has entered the hosts,
it spreads mainly by the lymphatic system but may be distributed by the circulatory system as well.
The disease typically follows a biphasic pattern. The first phase lasts 1-8 days after tick bite, in
which time the virus replicates (incubation period ranges from 4 to 28 days). First symptoms of
mild fever, nausea, headache, vomiting and myalgias emerge quickly. During this period, laboratory
test may present leukopenia, thrombocytopenia and a rise in albumin concentration in CSF. In 13-
26%  of  cases  the  disease  ends  in  the  first  phase,  rest  of  patients  enter  the  second  phase  –
neurological phase. The second phase includes fevers up to 40°C, headaches, nauseas, vomiting,
myalgia and meningeal symptoms. There are 4 subtypes of TBE [4,8]:
- Meningial – the most benign and common subtype of TBE
- Meningocerabral  –  more  severe  subtype  accompanied  by  symptoms/features
of encephalitis 
- Meningomyelocerebral  –  most  severe  subtype  with  symptoms  of  destruction  of  the
anterior spines of spinal cord, 10% of cases
Meningoencephalitis accompanied by meningeal symptoms
TBE mortality in Poland is 5%. 
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Most of the complications from TBE are neurological defects (35-59% of patients), some of
which  include:  muscular  atrophy  of  the  shoulder  girdle,  symptoms  suggesting  damage  to  the
cerebellum, cholinergic-mediated cognitive deficits, peripheral and/or facial nerve paresis or palsy.
Some cognitive  defects  resulting  from TBE complications  include  loss  of  consciousness,  sleep
disorders, concentration disorders and depression [13].
A case report 
A case report found on the PubMed database describes the case of a 65 year old male, who
after being bit by a tick was diagnosed with TBE based on presented symptoms and laboratory test
results. The patient suffered from headaches and disorientation which later progressed to motor
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ataxia and dyspraxia accompanied by fever and nuchal rigidity.  The symptoms were alleviated,
however three weeks later the patient developed symmetrical facial palsy, motor palsy of the upper
right and the lower left extremity (muscular reflexes remained intact). CSF was tested again and an
MRI scan was conducted. The results revealed pathological demyelization of both motor neurons
and sensory neurons. Based on further examination, the patient was diagnosed with Guillain-Barre
syndrome. The patient was treated with IVIG and early rehabilitation was started, which lead to a
gradual improvement of the patients condition [14]. This case presents symmetrical facial paralysis
where muscular reflexes remained intact which are features that have inducted into the diagnostic
criteria  for GBS [15].  Based on this  example TBEV is in  the group of flaviviruses  capable  of
inducing Guillain-Barre syndrome. 
Diagnosis and clinical procedure in TBE
In case of a suspicion of CNS infection by TBEV, a lumbar puncture needs to be performed
for a  pathomorphological  assessment  of the amount  and quality  of  CSF,  unless  there are  clear
contraindictions  for  the  procedure.  The  most  important  contraindiction  is  the  risk  of  cerebral
herniation,  leading to  the  compression  of  vital  areas  of  the  brainstem and abrupt  death.  Other
important contraindictions include infected tissues in near proximity of the puncture, blood clotting
disorders,  lack  of  patients  compliance  and  critical  condition  of  the  patient.  Brain  imaging
procedures lack sensitivity and specificity in diagnosing TBE however they are useful in differential
diagnosis of disorders with similar manifestations [10].
In case of cerebral oedema, increasing analgosedation is recommended. Osmotherapy and
corticosteroids are not recommended. In case the internal cranial pressure (ICP) continues to rise,
therapeutic hypothermia (lowering the patient’s body temperature to 32-34°C) should be considered
in order to prevent neurological damage. If epileptic seizures occur, they should be treated as other
symptomatic epileptic bouts. 
Vaccination
There are 4 anti-TBEV vaccines available in Poland: FSME-Immun 0,5 ml, FSME-Immun
0,25  ml  Junior,  Encepur  Adults,  Encepur  K.  In  the  Polish  Vaccination  Program,  since  2005,
vaccination against TBEV is a recommended vaccination, not financed by the Ministry of Health
budget.  The vaccines  are administered according to  the dosage and cycle  recommended by the
manufacturer  of  the  vaccine.  A  correctly  administered  vaccination  cycle  induces  permanent
resistance to TBEV in 98% of vaccinated population [9]. Some children don’t finish the vaccination
306
cycle. This is mainly due to the parents negligence and incomprehension of potential harm. The
parents awareness of the necessity of completing the vaccination cycle has to be improved because
only the completed vaccination cycle allows for a full and permanent resistance to TBE [12]. It
should  be noted  that  vaccination  against  TBEV  does  not  grant  resistance  to  borreliosis.  State
Hygiene Institute data analysis has shown an increasing interest in vaccination against TBE during
the 2014-2017 period [fig. 5]. Largest number of anti-TBEV vaccinations has been registered in
2009 and the lowest number was reached in 2014 [6]. Despite the growing number of vaccinated
population in Poland, the number of cases remains high. The frequency of registered TBE cases in
Europe  is  constantly  on  the  rise  largely  due  to the  spreading  of  the  endemic  region  and  the
prolongation of the annual period when the ticks remain active. This increase in TBE morbidity
poses a growing health risk to people within the endemic region [10]. In order to decrease the
annual number of registered cases and increase the number of vaccinated citizens, it is necessary to
educate the general public on the risk TBE poses and necessary prevention procedures. 
Vaccination against TBE is recommended to all age groups older than 12 months of age for
people inhabiting endemic regions (≥5 cases/100 000 citizens/year)  and to the population more
susceptible to TBEV infection living in non-risk areas. Individuals traveling to endemic regions
should be vaccinated if their visit will include outdoor recreational activity in green areas where the
risk of tick bite is heightened. Post expository prevention after tick bite is not recommended. 
Figure 5.  The number of cases and the number of vaccinations
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Summary
Tick-borne encephalitis (TBE) is a serious disease of the central nervous system that can
occur in many clinical forms. In Poland, TBE is the main cause of brain inflammation of viral
etiology. The diseases are characterized by seasonality and occur mainly in the spring and summer.
The highest number of cases occurred in 2010, and the lowest in 2015. In 2015/2016, the number
of cases with TBE increased almost twice. It was at the same level in 2017. Every year the highest
number of TBE cases is recorded in the region Podlasie and it accounts for about 80% of cases of
TBE in Poland. There is no causative treatment of TBE, the only form of prevention of the disease
are  protective  vaccinations,  which  in  Poland  are  recommended  for  specific  groups  of  people.
Analysis of TBE vaccination data has shown a gradual increase in the interest in TBE protective
vaccinations from 2014 to 2017. Despite the growing number of people vaccinated against TBE in
Poland, the number of cases remains high. The society in TBE prophylaxis should be educated.
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